Skip to content

Evaluation of Macular Nerve Cell Layer in Patients with Glaucoma Using Optical Eye Scans

Macular Ganglion cell layer imaging in glaucoma using Spectralis Optical Coherence Tomography - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/01/102182
Enrollment
74
Registered
2026-01-27
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H408- Other glaucoma Health Condition 2: H188- Other specified disorders of cornea

Interventions

Intervention1: Nil: Nil

Sponsors

Nethradhama Super Speciality Eye Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with a clinical diagnosis of primary open-angle glaucoma, primary angle-closure glaucoma, pseudoexfoliative glaucoma, or pigmentary glaucoma

Exclusion criteria

Exclusion criteria: Patients with media opacity interfering with good-quality OCT scans such as corneal opacity, cataracts,etc.; history of intraocular diseases; complicated intraocular surgery; nonglaucomatous secondary causes of elevated IOP (e.g. iridocyclitis and trauma); coexisting retinal disease (e.g. diabetic retinopathy); other diseases affecting visual field (e.g.pituitary lesions); taking medications known to affect visual field sensitivity; or with problems other than glaucoma affecting color vision were excluded from this study.

Design outcomes

Primary

MeasureTime frame
Primary outcome -To evaluate correlation between macular GCL thinning and visual field indices (MD, PSD).Timepoint: Follow up - day 1, 1 week, 6 weeks ,6 months

Secondary

MeasureTime frame
To determine the sensitivity of macular imaging for early detection of glaucomatous damage.Timepoint: Follow up - day 1, 1 week, 6 weeks ,6 months

Countries

India

Contacts

Public ContactDrSamra wahaj Fatima

Nethradhama Super Speciality Eye Hospital

wjsam19@gmail.com8374016816

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026